The idea of the study is the feasibility of a full-scale RCT evaluating angular manual traction (AMT) in patients with cervical radiculopathy (CR). AMT is widely used for moderate to severe cervicobrachial pain, but its efficacy has not yet been validated in rigorous fully randomized controlled trials[1]. The proposed external pilot RCT will enroll 48 participants with CR and cervicobrachial pain (NRS ≥ 4) in a five-period design and randomly assign them to either usual care or AMT plus usual care for 4 consecutive 7-day periods[1]. The primary outcome of the pilot will be feasibility, focusing on enrollment rates, retention rates, and protocol adherence; secondary outcomes include pain, upper extremity numbness, muscle weakness, upper extremity and neck function, analgesic consumption, work ability, quality of life, emotional well-being, and cost and safety of the intervention[1]. Results will be analyzed using linear mixed-effects models on efficacy ratings over time to assess changes within and between groups[1]. The trial is expected to be completed by June 2026 and pilot targets are defined as ≥25% enrolment, ≥80% adherence, ≥80% rescue from usual health outcome and ≥80% retention[1]. The aim of the pilot is to provide the feasibility and outcome variability data needed for sample calculations and planning of a subsequent definitive RCT on AMT in CR; sthuria is registered in the Chinese ChiCTR Clinical Trial Registry (ChiCTR2400087289)[1].